Hadrian raises $260M to build out automated factories for space and defense parts | TechCrunch https://t.co/CeUBldIiiU ...

Key Takeaways ROKU is trading at 42.86X cash flow, above the industry average of 34.28X, reflecting a premium valuation. Subscription growth, Apple and Amazon deals, and AI-powered features are boosting ROKU's engagement. ROKU holds $2.26B in cash with no long-term debt, supporting innovation and meeting working capital needs.Roku (ROKU) shares are trading at a premium, as suggested by a Value Score of D. In terms of the price-to-cash flow ratio, ROKU is currently trading at 42.86X, above the Zacks  Broad ...

You know, the fact of the matter is it's an automated system that helps the umpire. It doesn't the umpire doesn't become a robot. Um, you know, he's still the man behind the plate that runs the game.Um, but it is a really robust system. Um, you know, there's inherent value in getting calls right, particularly in high leverage situations. Um, and I think one of the beauties of ABS is that it takes virtually no time.I don't know if you've ever seen one, but the challenge happens, the umpire gets the answer in ...

Key Takeaways UAL's Q2 EPS of $3.87 beat estimates but fell 6.5% YoY; revenue rose 1.7% to $15.2B, missing projections. Load factor declined 1.1 pts to 83.1% as capacity grew faster than traffic; yields and unit revenues fell. UAL sees demand rebounding in H2 2025 and updated full-year EPS guidance to $9.00-$11.00.United Airlines Holdings, Inc. (UAL) reported mixed second-quarter 2025 results wherein the company’s earnings beat the Zacks Consensus Estimate, but revenues missed the same.UAL's second-quarte ...

It's been ~18 months since the spot Bitcoin ETFs began trading, and at this juncture, most investors have moved beyond the granular details in their preference for a specific ETF to gain direct exposure to Bitcoin (Mandela has been a cryptocurrency enthusiast and trader since 2017. He loves coding and writing about cryptocurrencies and crypto investment strategies. He has an in-depth understanding of distributed ledger technology, the Web3 technology stack, and crypto investing. He enjoys researching and an ...

Core Insights - The treatment landscape for primary biliary cholangitis (PBC) has significantly evolved with the recent approvals of Gilead's Livdelzi (seladelpar) and Ipsen's Iqirvo (elafibranor), marking progress in disease management [1] - Pruritus remains a significant unmet need for PBC patients, with many suffering from moderate to severe symptoms that impact their quality of life [2] Treatment Developments - GSK's linerixibat, an ileal bile acid transporter (IBAT) inhibitor, has had its New Drug Application accepted by the FDA for treating cholestatic pruritus in PBC patients, with a target action date of March 24, 2026 [3] - Gastroenterologists express a high likelihood of incorporating linerixibat into treatment if approved, noting its potential for significant symptom reduction despite concerns over side effects like abdominal pain and diarrhea [3] Market Analysis - Spherix Global Insights' Market Dynamix™ service provides analysis on markets expected to undergo significant changes in the next three to five years, focusing on market size, treatment approaches, unmet needs, and expert opinions on pipeline agents [4] - The service aims to track emerging developments in the PBC treatment landscape and pipeline, highlighting the ongoing demand for effective therapies targeting pruritus [3][4]

Key Takeaways ISRG received FDA clearance for its Vessel Sealer Curved, expanding its da Vinci surgical instrument lineup. ISRG's new tool performs four functions in one, improving control and efficiency in tight anatomical spaces. ISRG enhanced the design with better visibility and versatility, plus clearance to transect lymphatic vessels.Intuitive Surgical (ISRG) recently received FDA clearance for its Vessel Sealer Curved, a multifunctional instrument designed for use with compatible da Vinci surgical ...

Key Takeaways MDGL rose 10.9% as a new U.S. patent is set to protect Rezdiffra's FDA-approved dosing regimen. The patent, valid through 2044, will be listed in the FDA's Orange Book, blocking generic competition. Over 17,000 patients are already on Rezdiffra as MDGL expands clinical data to support full approval.Madrigal Pharmaceuticals (MDGL) shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark Office issued a Notice of Allowance for a new U.S. patent related to ...

SHENZHEN, China, July 17, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced that they have purchased up to $200 million in Bitcoin and cryptocurrency-related securities derivatives. As of July 17, the  cumulative investment income has reached $34.67million. HOLO currently holds $394 million in cash reserves. The company plans to allocate these $394 million reserves toward derivatives and technology development in cutting-edge fi ...

Financial Data and Key Metrics Changes - United Airlines reported a top line revenue increase of 1.7% to a record $15.2 billion in Q2 2025 [25] - Earnings per share (EPS) was $3.87, within guidance and ahead of Wall Street expectations of $3.81 [38] - The company generated over $1.1 billion in free cash flow and ended the quarter with $18.6 billion in liquidity [41][42] Business Line Data and Key Metrics Changes - International flying outperformed domestic, with a decrease in RASM of 1% for international compared to a 7% decrease for domestic [27] - Premium cabin revenues increased by 5.6% year over year, while economy cabin revenues were negative [28] - Cargo performance was strong, with revenue up 4% year over year on record volumes [28] Market Data and Key Metrics Changes - The demand environment showed a six-point positive swing in sales in July compared to Q2, with a double-digit increase in business revenues [31] - Newark's share of New York City sales has largely recovered in July, which is critical for revenue performance [29] - The overall demand environment has improved due to reduced macroeconomic uncertainty, leading to positive year-over-year yields for domestic ticket sales for the first time since February [31][96] Company Strategy and Development Direction - The company continues to focus on revenue diversity, including both basic economy and premium offerings, as a formula for industry-leading margins [12] - United Airlines plans to introduce the Polaris Studio Suite later this year to enhance premium capacity and revenue diversity [36] - The company is optimistic about future growth, particularly with the expected reduction in low-margin airline capacity [30][37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of demand and the operational improvements at Newark Airport, which is now performing better than ever [19][20] - The company anticipates continued stabilization in the geopolitical environment, which is expected to drive stronger bookings [40] - Management believes that the industry is transforming into a healthier state, with brand loyalty becoming increasingly important [39] Other Important Information - The company has reduced gross debt by almost $11 billion since the peak level during COVID [42] - United Airlines repurchased $235 million worth of shares during the quarter, leaving $829 million in authorization [43] - The company is targeting net leverage below two times and continues to work towards achieving investment grade [42] Q&A Session Summary Question: On cost performance and distribution expenses - Management highlighted strong cost performance with a 2.2% CASM ex growth in Q2 and noted a long-term trend of decreasing distribution expenses due to more customers choosing direct channels [48][50] Question: On demand recovery and current levels - Management confirmed a six-point inflection in demand compared to Q2, particularly strong for business traffic, and expressed optimism about the recovery trajectory [51][52] Question: On guidance and demand acceleration - Management explained that guidance is conservative, accounting for potential uncertainties, but recent strong bookings suggest that the guidance may prove conservative [60] Question: On competitive positioning against Delta - Management emphasized a focus on returning to solid double-digit margins and highlighted the structural advantages of United's hubs and brand loyalty [71][72] Question: On the Connected Media initiative - Management indicated that they are working on building the technology stack and client roster for Connected Media, aiming to double revenues in 2025 compared to 2024 [114] Question: On fleet deliveries and supply chain - Management reported that Boeing is performing well with narrow-body deliveries, while wide-body deliveries are still uncertain due to engine constraints [118]